Healthcare -
Biotechnology - NASDAQ - US
$ 6.45
-4.02 %
$ 143 M
Market Cap
-2.96
P/E
Price Target
Average
241.09%
Revenue Forecast
Estimate
755.66%
EBIT
Estimate
--39.08%
Net Income
Estimate
27.58%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
INmune Bio, Inc.
Wall Street analysts predict an average 1-year price target for INMB of $22 , with forecasts ranging from
a
low of
$22 to a high of $22 .
INMB Lowest Price Target
Wall Street Target
22 USD
241.09%
INMB Average Price Target
Wall Street Target
22 USD
241.09%
INMB Highest Price Target
Wall Street Target
22 USD
241.09%
REVENUE FORECAST
Revenue Forecast Chart INMB
EBIT FORECAST
EBIT Forecast Chart INMB
NET INCOME FORECAST
Net Income Chart INMB